Medical Devices & Life Sciences Life sciences compliance
Know the customs history you're buying.
After a deal, seven ERPs hold seven answers for the same kit. GingerOS brings them into one record per product, with the reasoning, so every device and consumable has one code.
GingerOS- HTS
8421.29.0065- Origin
- China
- Imported by
- Acquired entity, ERP 4 of 7
- Entry
- 10/06/2026
Duty stackTotal duty37.5%
- Base duty (MFN)
Free - Section 301, List 1
9903.88.0125% - Section 301, forced labor
9903.05.3112.5% - Section 232, steel derivativeSteel is under 15% of the column's weight
9903.82.10Not applied
Plus MPF 0.3464%, and HMF 0.125% by ocean
Why A polymer-housed prepacked column is 8421.29 (CBP ruling N350390), free at the base rate. From China it carries List 1 and the 12.5% forced-labor line; USTR declined to exempt devices.
A GingerOS part record with demo data for medical devices & life sciences: Prepacked chromatography column, single-use, HTS 8421.29.0065, from China. Each duty layer is listed with its rate or exemption, for a total duty of 37.5%.
What tariffs hit medical and life sciences imports now?
Devices pay the forced-labor 301, patented drugs pay the 232 pharma tariff, and most finished drugs are exempt from the 301.
Medical devices and lab consumables mostly enter at a free base rate, but since July 24, 2026 they pay the Section 301 forced-labor duty: a combined 10% from the EU, 12.5% from Japan, and 12.5% on top of the China-list rate from China. USTR declined to exempt devices. Many finished drugs and biologics are exempt, while patented drugs and their ingredients pay the Section 232 pharmaceutical tariff, in force for all companies since September 29, 2026. Chinese gloves and masks rose in January.
Recent Policy UpdatesNotices that touch devices, drugs and consumables
- Presidential ProclamationProclamation 11020Section 232 pharma tariff in force for all companies since September 29; devices out
Patented drugs and their ingredients pay 100% combined by default, 15% from the EU and Japan; generics are exempt and drawback is available.
Listed Ch. 29, 30 lines; 9903.04.60 to .70Read the explainer - Federal Register Notice91 FR 47318Forced-labor Section 301 hits devices and lab consumables; most Ch. 30 drugs exempt
Free-rated Chapter 90 devices and bioprocess consumables now pay 10% from the EU, 12.5% from Japan and 12.5% on top from China.
9018, 9021, 9027, 3822, 8421; exemptions 9903.05.86, .89, .90Read the explainer - HTS USITC ArchiveCh. 99 note 31(h), (i)China Section 301: medical gloves rise to 100%, textile masks to 50%
Syringes and needles have carried 100% since 2024; the 12.5% forced-labor duty stacks on all of them.
4015.12.10, 6307.90.98; 9903.91.07, .08 - Federal Register Notice90 FR 55232178 China Section 301 exclusions, including some medical devices, expire November 9
Certain blood pressure monitors, pulse oximeters, anesthetic instruments and sterile drapes lose their exclusion after 11:59 p.m. on November 9.
9903.88.69, 9903.88.70Read the explainer
A Compliance Radar feed of 4 recent policy updates that touch medical devices & life sciences, each with its source, reference and effective date.
What gives this test kit its character?
If the electronic reader carries the kit, it is 9027.50 with China List 1; if the reagents do, it is 3822 with no China-list duty.
Point-of-care test kit: reagent cartridge, swab, sample vial and a battery-powered reader that heats the sample and reads the result. Put up together for sale.
Ginger asksDoes the kit include an electronic reader that runs or reads the test, or only reagents and passive plastic parts?
It includes the reader. The test cannot be read without it.
9027.50.4015HTS rate Free
Instruments using optical radiation, electrical: chemical analysis
From China: List 1 25% and forced-labor 301 12.5%
3822.19.0080HTS rate Free
Diagnostic or laboratory reagents, whether or not in kits: other
No China-list duty; forced-labor 301 12.5% from China
Deciding rule GRI 3(b): a kit put up for sale takes the character of the component that defines it; CBP ruling N325218 (2022) held the electronic test unit, not the reagents, gave a test kit its essential character.
A Classification Researcher conversation with demo data. Ginger asks: Does the kit include an electronic reader that runs or reads the test, or only reagents and passive plastic parts? From the answer it picks HTS 9027.50.4015 over 3822.19.0080.
What lands on one compliance manager after a deal?
Seven ERPs of codes become one record per product, and every kit, device or new origin gets a recheck.
GingerOSHow much customs history did the company we are buying leave behind, and what is the kit's essential character?
Open rechecks3
3822.19.0080Acquired entity, ERP 4 of 7Target filed it as a reagent kitRecheck GRI 3(b): the reader may carry the kitRuns in Classification ResearcherNeeds answer8421.29.0065Acquired entity, ERP 4 of 7Forced-labor 301 on goods of ChinaRecalculate China and Germany landed costRuns in Tariff CalculatorRunning9018.19.9530Devices entity, USChina 301 exclusion ends November 9Recalculate tariffs from November 10Runs in Compliance RadarReviewA GingerOS window with demo data. Someone asks: "How much customs history did the company we are buying leave behind, and what is the kit's essential character?" It lists 3 open rechecks, each with the part, HTS code, trigger, tool and status.
Questions about life sciences compliance
How far back does an acquired company's customs exposure reach?
Generally five years. A penalty claim under 19 U.S.C. 1592 must be brought within five years of the violation, or of its discovery for fraud (19 U.S.C. 1621), and importers must keep entry records for five years from entry (19 CFR 163.4). Liquidated entries can be protested only within 180 days of liquidation, so diligence should pull five years of the target's entry and classification data.
How is the essential character of a diagnostic kit decided?
By the component that gives the set its essential character under GRI 3(b), once GRI 1 does not settle it. In NY N325218 (2022), CBP held that a COVID-19 test kit's electronic test unit, not its reagents, gave essential character, so the kit went to 9027.50.4015 rather than reagent heading 3822. Components shipped in bulk are classified separately.
Does the Section 232 pharmaceutical tariff apply to medical devices or diagnostics?
No. Proclamation 11020 covers patented drugs and their active ingredients and key starting materials in the Chapter 29 and 30 provisions listed in U.S. note 40(c); devices and heading 3822 reagents are not on that list. A separate Section 232 investigation of PPE, medical consumables and medical equipment, opened September 2, 2025 (90 FR 46383), has produced no proclamation as of October 6, 2026.
Are medical devices exempt from the Section 301 forced-labor duty?
No. USTR received requests to exempt medical devices and declined to add them (91 FR 47318), so a free-rated device or bioprocess consumable from Germany pays a combined 10% and one from Japan 12.5%. Many finished drugs and biologics in Chapter 30 are exempt under U.S. note 52(b), and patented drugs under the Section 232 pharmaceutical tariff are exempt under note 52(f)(8).
What duty does a single-use chromatography column from China pay now?
About 37.5% plus fees for a plastic-housed column in 8421.29.0065: a free base rate, 25% under Section 301 List 1 (9903.88.01) and 12.5% under the forced-labor action (9903.05.31). If steel is at least 15% of the article's weight, the Section 232 derivative duty applies instead of the forced-labor duty (U.S. notes 16(c) and 52(f)(1)).
Which Chinese medical products got higher Section 301 rates in 2026?
Rubber medical and surgical gloves in 4015.12.10 rose to an additional 100%, and textile respirators and face masks to 50%, on January 1, 2026, under headings 9903.91.08 and 9903.91.07. Syringes and needles in 9018.31 and 9018.32 have carried 100% since September 27, 2024 (9903.91.03). The 12.5% forced-labor duty stacks on top for China.
When do the remaining China Section 301 exclusions for medical products end?
At 11:59 p.m. eastern time on November 9, 2026. USTR extended 178 exclusions, including certain blood pressure monitors, pulse oximeters, anesthetic instruments and sterile surgical drapes, from November 30, 2025 (90 FR 55232). After that the underlying Section 301 rate applies unless USTR extends them again, so 2027 sourcing should be priced without them.
What Section 232 rate applies to a patented drug imported from the EU?
A combined 15%, meaning the Column 1 rate plus the Section 232 duty totals 15% under heading 9903.04.62 (Proclamation 11020). It applied from July 31, 2026 for the companies listed in Annex III and from September 29, 2026 for all others. Generics and biosimilars are not covered, the UK pays no added duty (heading 9903.04.63), and an FTA preference does not remove the duty.
